Integrating ultrasound and serum indicators for evaluating outcomes of targeted immunotherapy in advanced liver cancer
TIPM provides a robust tool for predicting targeted immunotherapy efficacy in advanced HCC, facilitating personalized treatment planning.
Authors
- Xiaojian Ye (ORCID: https://orcid.org/0000-0003-2402-5782)
- Ju-Zhen Zhang
- Haibin Tu (ORCID: https://orcid.org/0000-0003-4540-9937)
- Yujie Huang (ORCID: https://orcid.org/0000-0002-0751-6478)
- Lihong Chen (ORCID: https://orcid.org/0000-0001-6370-1865)
- Siyi Feng
- Dingluan Lin
- Sheng-Xuan Peng
Institutions
- Fujian Medical University (CN)
- Mengchao Hepatobiliary Hospital (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-05-15
- DOI
- https://doi.org/10.4251/wjgo.v17.i5.105872
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32